Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Noxsano
AddedFeb 16, 2024
UpdatedJul 17, 2026
Noxsano

Noxsano

Series A

Noxsano Inc. develops easy-to-use devices and salves for controlled, localized chronic wound treatment.

HQ
Columbus, OH, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Noxsano Inc., founded with a mission to revolutionize chronic wound care, focuses on developing innovative devices and salves that deliver controlled, localized treatment. Their core technology utilizes nitric oxide delivery to enhance healing, reduce the frequency of dressing changes, and lower overall treatment costs. Noxsano's products are designed to be user-friendly and effective, making them suitable for both human and veterinary applications.

Notable figures associated with Noxsano include experts in medical device development and wound care specialists. The company has attracted significant attention from investors interested in healthcare innovation. Key achievements include successful clinical trials demonstrating faster healing times and reduced treatment costs. Noxsano's impact is evident in its potential to improve patient outcomes and streamline wound care management across various settings.

Noxsano - Similar Companies

Noctrix Health logo

Noctrix Health

noctrixhealth.com

Sano logo

Sano

sanodx.com

Noxilizer logo

Noxilizer

noxilizer.com

SaNOtize logo

SaNOtize

sanotize.com

Nuo Therapeutics logo

Nuo Therapeutics

nuot.com

Nasus Medical logo

Nasus Medical

nasusmedical.com

Nocira logo

Nocira

nocira.com

Clozex Medical logo

Clozex Medical

clozex.com

Nitric Bio logo

Nitric Bio

NanoDx logo

NanoDx

Nesos logo

Nesos

nesos.com

Vaporox logo

Vaporox

RenovoDerm logo

RenovoDerm

Guard Medical logo

Guard Medical

guard-medical.com

XN Health logo

XN Health

xn-health.com

Noxsano - Quick Facts

Who are Noxsano's competitors?

Companies similar to Noxsano include Noctrix Health, Sano, Noxilizer and SaNOtize.

When was Noxsano founded?

Noxsano was founded in 2016.

Where is Noxsano's headquarters located?

Noxsano's headquarters is located in Columbus, OH, US.

When was Noxsano's last funding round?

Noxsano's most recent funding round was for $800k (USD) in July 2022.

How much has Noxsano raised to-date?

As of Jul 1, 2022, Noxsano has raised a total of $3M (USD).

How many employees does Noxsano have?

Noxsano has 9 employees as of Feb 4, 2024.

Noxsano - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified